<?xml version="1.0"?>

<document>
	<title>Complement in cystic fibrosis.</title>

	<author>Gotz-M.</author>
	<author>Lubec-G.</author>

	<source>Eur-J-Pediatr. 1978 Jan 17. 127(2). P 133-9.</source>

	<abstract>Complement components C3, C4, and C3A were estimated in 30 patients
   with cystic fibrosis aged 1 to 21 years (M:F = 16:14) and were
   compared with results in 40 healthy, age-matched subjects. The
   influences of the clinical score, sputum microbiology, and the
   patients&apos; sex were also investigated. In contrast to most previous
   communications, this paper shows that, compared to the control group,
   a significant decrease of C3 (P less than 0.001) and C4 (P less than
   0.02) was observed whereas C3A levels were not altered. There were no
   increases in complement. Shwachman-scores above or below 70 did not
   influence the complement levels, nor did exacerbations of the disease
   change the levels. No influence of the patients&apos; sex could be shown.
   Pseudomonas aer. in the sputum was clearly associated with complement
   defects (14/18). Alternative-pathway involvement of complement
   activation could be demonstrated in 32%. The results make complement
   activation due to pulmonary infection most likely. The defects
   observed probably represent secondary changes.</abstract>

	<majorsubject>COMPLEMENT: an</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: im</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>COMPLEMENT-3: an</minorsubject>
	<minorsubject>COMPLEMENT-4: an</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>INFANT</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PSEUDOMONAS-AERUGINOSA</minorsubject>
	<minorsubject>SEX-FACTORS</minorsubject>
	<minorsubject>SPUTUM: mi</minorsubject>

	<reference>001   ALPER CA              N ENGL J MED                   288   601 973</reference>
	<reference>002   ALPER CA              IN: NETER E                              975</reference>
	<reference>003   BEDROSSIAN CWM        HUM PATHOL                       7   195 976</reference>
	<reference>004   CHARLESWORTH JA       J CLIN INVEST                   53  1578 974</reference>
	<reference>005   CONOVER JH            LANCET                           2  1501 973</reference>
	<reference>006   CONOVER JH            LANCET                           1    47 975</reference>
	<reference>007   CONOVER JH            LIFE SCI                        14   253 974</reference>
	<reference>008   DANES BS              J EXP MED                      129   775 969</reference>
	<reference>009   ESTERLY JR            IN: MANGOS JA                        115 976</reference>
	<reference>010   FEARON DT             N ENGL J MED                   292   937 975</reference>
	<reference>011   FUST G                CLIN IMMUNOL IMMUNOPATHOL        5   293 976</reference>
	<reference>012   GIBBONS A             BR MED J                         1   120 976</reference>
	<reference>013   GIBSON LE             PEDIATRICS                      23   545 959</reference>
	<reference>014   GOETZ M               PROC EWGCF 6TH ANNU MTG                  975</reference>
	<reference>015   HANN S                LANCET                           2   520 974</reference>
	<reference>016   HANSSON LO            LANCET                           2   874 975</reference>
	<reference>017   HARPER BL             CF CLUB ABST                    17    20 976</reference>
	<reference>018   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   83   459 975</reference>
	<reference>019   HOLZHAUER RJ          CF CLUB ABST                    17    22 976</reference>
	<reference>020   JOHNSTON RB           J PEDIATR                       90   169 977</reference>
	<reference>021   KAY AB                LANCET                           2   916 974</reference>
	<reference>022   LEDERBERG S           AM J HUM GENET                  28   597 976</reference>
	<reference>023   LEDERBERG S           AM J HUM GENET                  28   597 976</reference>
	<reference>024   MCFARLANE H           BR MED J                         1   423 975</reference>
	<reference>025   OSOFSKY SG            J PEDIATR                       90   180 977</reference>
	<reference>026   PALMER DG             AUST NZ J MED                    6   349 976</reference>
	<reference>027   POLMAR SH             IN: KIRKPATRICK CH                   191 976</reference>
	<reference>028   ROSSMAN CM            J PEDIATR                       90   579 977</reference>
	<reference>028A  ROY CC                PEDIATR CLIN GASTROENTEROL               975</reference>
	<reference>029   SCANLIN TF JR         LANCET                           1  1382 974</reference>
	<reference>030   STEPHAN U             PEDIATRICS                      55    35 975</reference>
	<reference>031   TAUSSIG LM            CF CLUB ABST                    17    21 976</reference>
	<reference>032   WEEKE B               DAN MED BULL                    23   155 976</reference>
	<reference>033   WOOD RE               AM REV RESPIR DIS              111   733 975</reference>
	<reference>034   WOOD RE               AM REV RESPIR DIS              113   833 976</reference>

	<citation>1   SCHIOTZ PO            MONOGR PAEDIATR                 10   131 979</citation>
	<citation>2   STRAUSS RG            HELV PAEDIATR ACTA              34   429 979</citation>
	<citation>3   HODSON ME             THORAX                          35   801 980</citation>
	<citation>4   MOSS RB               AM REV RESPIR DIS              121    23 980</citation>
	<citation>5   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C) S276     1 981</citation>
	<citation>6   FICK RB               J CLIN INVEST                   68   899 981</citation>
	<citation>7   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982</citation>
	<citation>8   WISNIESKI JJ          AM REV RESPIR DIS              132   770 985</citation>
	<citation>9   FICK RB               PEDIATR RES                     20  1258 986</citation>

</document>
